Tandem upgraded, Insulet downgraded at Stifel on market for tubeless insulin pumps
· seekingalpha.com
Tandem Diabetes Care (TNDM) stock gains and Insulet (PODD) slips as Stifel changes their ratings, citing the market trends for tubeless insulin pumps. Read more here.
Search field
Entering text into the input field will update the search result below